title: Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaign.
abstract: The family of signal transducers and activators of transcription (STATs) consists of seven transcription factors that respond to a variety of cytokines, hormones, and growth factors. STATs are activated by tyrosine phosphorylation, which results in their dimerization and translocation into the nucleus where they exert their effect on transcription of regulated target genes. The phosphorylation of STATs is mediated mainly by Janus kinases (JAKs). The JAK/STAT pathway plays a critical role in hematopoietic and immune cell function. Here we focus on one member of the STAT family, STAT5. STAT5 is phosphorylated by several JAKs, including Jak3, Jak2, and Tyk2, in response to interleukin-2, erythropoietin (EPO), and interleukin-22, respectively. Activation of STAT5 is essential to T cell development and has been associated with hematologic malignancies. Therefore, the ability to assess STAT5 phosphorylation is important for discovery efforts targeting these indications. The assay formats available to detect phosphorylated STAT5 (pSTAT5) are relatively low throughput and involve lengthy protocols. These formats include western blot analysis, enzyme-linked immunosorbent assay (ELISA), and flow cytometry. The SureFire (Perkin Elmer, Waltham, MA) pSTAT5 assay is a homogeneous assay that utilizes AlphaScreen (Perkin Elmer) technology to detect pSTAT5 in cell lysates. We have used this assay format to evaluate EPO-induced STAT5 phosphorylation in HEL cells and successfully complete a small-scale screening campaign to identify inhibitors of this event. The results obtained in these studies demonstrate that the SureFire pSTAT5 assay is a robust, reliable assay format that is amenable to high-throughput screening (HTS) applications.
authors.affiliation: Amgen Inc., Cambridge, Massachusetts, USA.
authors.forename: Christina
authors.initials: C
authors.lastname: Binder
authors.forename: Amy
authors.initials: A
authors.lastname: Lafayette
authors.forename: Ivonne
authors.initials: I
authors.lastname: Archibeque
authors.forename: Yu
authors.initials: Y
authors.lastname: Sun
authors.forename: Cherylene
authors.initials: C
authors.lastname: Plewa
authors.forename: Angus
authors.initials: A
authors.lastname: Sinclair
authors.forename: Renee
authors.initials: R
authors.lastname: Emkey
mesh_terms: D016477:Artifacts; D015153:Blotting, Western; D002460:Cell Line; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D004921:Erythropoietin / Q000494:pharmacology; D005189:False Positive Reactions; D005434:Flow Cytometry; D006801:Humans; D053612:Janus Kinases / Q000502:physiology; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology; D010766:Phosphorylation; D017467:Receptors, Erythropoietin / Q000235:genetics / Q000502:physiology; D015203:Reproducibility of Results; D050799:STAT5 Transcription Factor / Q000737:chemistry*
chemical_list: D017467:Receptors, Erythropoietin; D050799:STAT5 Transcription Factor; D004921:Erythropoietin; D053612:Janus Kinases; D004121:Dimethyl Sulfoxide